LAVA Therapeutics (LVTX) Institutional Ownership $2.07 -0.04 (-1.90%) (As of 07/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for LAVA Therapeutics (NASDAQ:LVTX)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$129.42KNumber ofInstitutional Sellers(last 12 months)0 Get LVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling LAVA Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LVTX Institutional Buying and Selling by Quarter Ad Crypto 101 MediaNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…Check out the new "Crypto Bull Run Millionaire Blueprint" now! LAVA Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/24/2024 Pathway Financial Advisors LLC60,000$108K0.0%+328.6%0.000% 4/10/2024 Pathway Financial Advisors LLC14,000$47K0.0%N/A0.000% 5/12/2023Bruce & Co. Inc.671,874$1.12M0.3%+571.9%2.650% 2/10/2023PNC Financial Services Group Inc.50,000$175K0.0%N/A0.197% 2/1/2023Bank of Montreal Can89,600$530K0.0%N/A0.353% 11/14/2022UBS Oconnor LLC75,000$343K0.0%N/A0.296% Get the Latest News and Ratings for LVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/28/2022Silverarc Capital Management LLC610,809$2.79M0.9%N/A2.409% 8/16/2022DAFNA Capital Management LLC128,335$379K0.1%-7.9%0.506% 8/15/2022Nantahala Capital Management LLC322,980$953K0.0%-3.3%1.274% 2/14/2022Point72 Asset Management L.P.119,152$655K0.0%-3.8%0.470% 11/15/2021Point72 Asset Management L.P.123,911$734K0.0%N/A0.489% 11/15/2021AXA S.A.229,121$1.36M0.0%+3.8%0.904% 11/12/2021Falcon Edge Capital LP140,229$830K0.1%-3.2%0.553% 8/17/2021Woodline Partners LP86,904$946K0.0%-23.3%0.343% 8/17/2021Millennium Management LLC138,831$1.51M0.0%-38.6%0.548% 8/16/2021Redmile Group LLC2,816,196$30.64M0.5%-0.3%11.108% 8/13/2021Geode Capital Management LLC12,997$141K0.0%N/A0.051% 8/11/2021 Bank of New York Mellon Corp25,288$275K0.0%-26.3%0.100% 8/10/2021Nicholas Investment Partners LP781,867$8.51M0.5%-4.0%3.084% 8/2/2021New York State Common Retirement Fund19,136$208K0.0%-26.3%0.075% 5/27/2021Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021Millennium Management LLC226,205$3.44M0.0%N/A0.892% 5/18/2021Point72 Asset Management L.P.5,561$84K0.0%N/A0.022% 5/18/2021Tudor Investment Corp Et Al19,614$298K0.0%N/A0.077% 5/18/2021Redmile Group LLC2,824,409$42.90M0.6%N/A11.141% 5/18/2021Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021Citadel Advisors LLC60,442$918K0.0%N/A0.238% 5/18/2021Falcon Edge Capital LP150,454$2.29M0.1%N/A0.593% 5/17/2021Point72 Hong Kong Ltd9,355$142K0.0%N/A0.037% 5/17/2021Woodline Partners LP113,242$1.72M0.0%N/A0.447% 5/17/2021 Caas Capital Management LP30,000$456K0.0%N/A0.118% 5/17/2021Pinz Capital Management LP25,900$393K0.1%N/A0.102% 5/17/2021Sphera Funds Management LTD.213,894$3.25M0.2%N/A0.844% 5/17/2021Novo Holdings A S3,327,312$50.54M2.1%N/A13.124% 5/14/2021Nantahala Capital Management LLC381,227$5.79M0.2%N/A1.504% 5/14/2021Nicholas Investment Partners LP814,840$12.38M0.9%N/A3.214% 5/14/2021Monashee Investment Management LLC265,000$3.02M0.5%N/A1.045% 5/13/2021 Bank of New York Mellon Corp34,319$521K0.0%N/A0.135% 5/12/2021Pura Vida Investments LLC54,000$820K0.0%N/A0.213% (Data available from 1/1/2016 forward) LVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LVTX shares? During the previous two years, the following institutional investors and hedge funds held shares of LAVA Therapeutics shares: Silverarc Capital Management LLC ($2.79M), Bruce & Co. Inc. ($1.12M), Nantahala Capital Management LLC ($953K), Bank of Montreal Can ($530K), DAFNA Capital Management LLC ($379K), UBS Oconnor LLC ($343K), and PNC Financial Services Group Inc. ($175K).Learn more on LVTX's institutional investors. Which institutional investors have been buying LAVA Therapeutics stock? The following institutional investors have purchased LAVA Therapeutics stock in the last 24 months: Silverarc Capital Management LLC ($610.81K), Bruce & Co. Inc. ($571.87K), Bank of Montreal Can ($89.60K), UBS Oconnor LLC ($75K), Pathway Financial Advisors LLC ($60K), and PNC Financial Services Group Inc. ($50K). How much institutional buying is happening at LAVA Therapeutics? Institutional investors have bought a total of 1,457,283 shares in the last 24 months. This purchase volume represents approximately $4.70M in transactions. Which LAVA Therapeutics major shareholders have been selling company stock? The following institutional investors have sold LAVA Therapeutics stock in the last 24 months: Nantahala Capital Management LLC ($11.18K), and DAFNA Capital Management LLC ($11.00K). How much institutional selling is happening at LAVA Therapeutics? Institutional investors have sold a total of 22,181 shares in the last 24 months. This volume of shares sold represents approximately $65.43K in transactions. Related Companies: Evelo Biosciences Major Shareholders Grifols Major Shareholders NLS Pharmaceutics Major Shareholders Pharvaris Major Shareholders Adicet Bio Major Shareholders Shattuck Labs Major Shareholders Editas Medicine Major Shareholders Eli Lilly and Company Major Shareholders Novo Nordisk A/S Major Shareholders Johnson & Johnson Major Shareholders This page (NASDAQ:LVTX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.